Document Classification

Section Type: RESULTS

Text: Intention-to-treat analysis showed no differences between patients according to whether they had or did not have a donor in disease-free survival (39 %, 95 % CI 30-48 % vs. 33 %, 95 % CI 23-41 %) and overall survival (44 %, 95 % CI 35-52 % vs. 35 %, 95 % CI 25-44 %), as well as for autologous SCT vs. chemotherapy comparisons (disease-free survival : 40 %, 95 % CI 28-52 % vs. 51 %, 95 % CI 37-67 % ; overall survival : 43 %, 95 % CI 29-58 % vs. 52 %, 95 % CI 39-65 %).